Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder Paul Vigano sold 3,000,000 shares of the stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total value of $24,030,000.00. Following the completion of the sale, the insider owned 190,130 shares of the company’s stock, valued at approximately $1,522,941.30. This trade represents a 94.04% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
Aveanna Healthcare Trading Up 3.7%
Shares of AVAH traded up $0.33 during mid-day trading on Thursday, hitting $9.19. 1,002,532 shares of the company’s stock traded hands, compared to its average volume of 1,480,237. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.73 and a 1 year high of $10.32. The firm has a market capitalization of $2.00 billion, a P/E ratio of 7.78, a PEG ratio of 0.88 and a beta of 1.89. The business’s 50-day moving average price is $7.25 and its 200-day moving average price is $7.56.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last announced its quarterly earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. The company had revenue of $647.91 million during the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The company’s revenue was up 15.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current fiscal year.
Hedge Funds Weigh In On Aveanna Healthcare
Analyst Upgrades and Downgrades
AVAH has been the topic of several research analyst reports. Royal Bank Of Canada upgraded shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price target on the stock in a research report on Wednesday, June 3rd. Barclays reduced their target price on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a report on Monday, May 18th. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $10.00 to $11.00 in a research report on Friday, May 15th. BMO Capital Markets dropped their price target on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. Finally, Truist Financial upped their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research note on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Aveanna Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $10.50.
View Our Latest Research Report on Aveanna Healthcare
About Aveanna Healthcare
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Featured Stories
- Five stocks we like better than Aveanna Healthcare
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
